Severe pediatric obesity (class II or higher; body mass index [calculated as weight in kilograms divided by height in meters squared] ≥120% above the 95th percentile or ≥35) is a national public health crisis affecting more than 4.5 million children and adolescents in the United States. The prevalence of severe pediatric obesity has increased from 4.0% in 2000 to 6.0% in 2016.1 For children and adolescents with this disease, metabolic and bariatric surgery (MBS) is effective in achieving long-term weight loss and resolution of comorbidities.2,3 We sought to define contemporary trends in the use of MBS among US children, adolescents, and young adults with severe obesity.
Griggs CL, Perez NP, Goldstone RN, et al. National Trends in the Use of Metabolic and Bariatric Surgery Among Pediatric Patients With Severe Obesity. JAMA Pediatr. 2018;172(12):1191–1192. doi:10.1001/jamapediatrics.2018.3030
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: